Inflammatory Resolution: new opportunities for drug discovery
Top Cited Papers
- 1 May 2004
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Reviews Drug Discovery
- Vol. 3 (5), 401-416
- https://doi.org/10.1038/nrd1383
Abstract
No abstract availableKeywords
This publication has 140 references indexed in Scilit:
- Modulation of inflammation and response to dexamethasone by Annexin 1 in antigen‐induced arthritisArthritis & Rheumatism, 2004
- A decade of caspasesOncogene, 2003
- Potentiation of Protein Kinase C ζ Activity by 15-Deoxy-Δ12,14-Prostaglandin J2 Induces an Imbalance between Mitogen-Activated Protein Kinases and NF-κB That Promotes Apoptosis in MacrophagesMolecular and Cellular Biology, 2003
- Adenosine A2A or A3 receptors are required for inhibition of inflammation by methotrexate and its analog MX‐68Arthritis & Rheumatism, 2003
- Aberrant inflammation and resistance to glucocorticoids in Annexin 1−/−MouseThe FASEB Journal, 2002
- Adhesion Molecule–dependent Mechanisms Regulate the Rate of Macrophage Clearance During the Resolution of Peritoneal InflammationThe Journal of Experimental Medicine, 2002
- Natural ligands of PPARγ:: Are prostaglandin J2 derivatives really playing the part?Cellular Signalling, 2002
- NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune ResponsesAnnual Review of Immunology, 1998
- Lipoxin A4 and B4 are potent stimuli for human monocyte migration and adhesion: selective inactivation by dehydrogenation and reduction.The Journal of Experimental Medicine, 1996
- Transcellular conversion of endogenous arachidonic acid to lipoxins in mixed human platelet-granulocyte suspensionsBiochemical and Biophysical Research Communications, 1988